Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pavo

Showing results (241-250 of 328) with videos related to

Pageof 33
Sort By:
F1000Research|March 21, 2017
Inhibition of CD34+ cell migration by matrix metalloproteinase-2 during acute myocardial ischemia, counteracted by ischemic preconditioningDominika Lukovic, Katrin Zlabinger, Alfred Gugerell, et al.
European Journal of Preventive Cardiology|May 21, 2023
Obesity in heart failure with preserved ejection fraction with and without diabetes: risk factor or innocent bystander?Suriya Prausmüller, Annika Weidenhammer, Gregor Heitzinger, et al.
Bone|June 29, 2007
Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosisJan J Stepan, David B Burr, Imre Pavo, et al.
Acta Diabetologica|May 24, 2019
Insulin exposure mitigates the increase of arterial stiffness in patients with type 2 diabetes and albuminuria: an exploratory analysisDaniel Gordin, Markku Saraheimo, Jaana Tuomikangas, et al.
Cardiovascular Diabetology|February 10, 2024
Reduction of prevalence of patients meeting the criteria for metabolic syndrome with tirzepatide: a post hoc analysis from the SURPASS Clinical Trial ProgramStephen J Nicholls, Santiago Tofé, Carel W le Roux, et al.
Cells|November 27, 2021
Relevance of Neutrophil Neprilysin in Heart FailureSuriya Prausmüller, Georg Spinka, Henrike Arfsten, et al.
Lancet (London, England)|October 21, 2021
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trialStefano Del Prato, Steven E Kahn, Imre Pavo, et al.
European Journal of Clinical Investigation|August 30, 2019
GDF-15 in solid vs non-solid treatment-naïve malignanciesHenrike Arfsten, Anna Cho, Claudia Freitag, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 7, 2021
Validation of the Surrogate Threshold Effect for Change in Bone Mineral Density as a Surrogate Endpoint for Fracture Outcomes: The FNIH-ASBMR SABRE ProjectRichard Eastell, Eric Vittinghoff, Li-Yung Lui, et al.
BMJ (Clinical Research Ed.)|July 1, 2021
Burden, treatment use, and outcome of secondary mitral regurgitation across the spectrum of heart failure: observational cohort studyPhilipp E Bartko, Gregor Heitzinger, Noemi Pavo, et al.
Pageof 33

Showing results (241-250 of 328) with videos related to

Sort By:
Pageof 33
F1000Research|March 21, 2017
Inhibition of CD34+ cell migration by matrix metalloproteinase-2 during acute myocardial ischemia, counteracted by ischemic preconditioningDominika Lukovic, Katrin Zlabinger, Alfred Gugerell, et al.
European Journal of Preventive Cardiology|May 21, 2023
Obesity in heart failure with preserved ejection fraction with and without diabetes: risk factor or innocent bystander?Suriya Prausmüller, Annika Weidenhammer, Gregor Heitzinger, et al.
Bone|June 29, 2007
Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosisJan J Stepan, David B Burr, Imre Pavo, et al.
Acta Diabetologica|May 24, 2019
Insulin exposure mitigates the increase of arterial stiffness in patients with type 2 diabetes and albuminuria: an exploratory analysisDaniel Gordin, Markku Saraheimo, Jaana Tuomikangas, et al.
Cardiovascular Diabetology|February 10, 2024
Reduction of prevalence of patients meeting the criteria for metabolic syndrome with tirzepatide: a post hoc analysis from the SURPASS Clinical Trial ProgramStephen J Nicholls, Santiago Tofé, Carel W le Roux, et al.
Cells|November 27, 2021
Relevance of Neutrophil Neprilysin in Heart FailureSuriya Prausmüller, Georg Spinka, Henrike Arfsten, et al.
Lancet (London, England)|October 21, 2021
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trialStefano Del Prato, Steven E Kahn, Imre Pavo, et al.
European Journal of Clinical Investigation|August 30, 2019
GDF-15 in solid vs non-solid treatment-naïve malignanciesHenrike Arfsten, Anna Cho, Claudia Freitag, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 7, 2021
Validation of the Surrogate Threshold Effect for Change in Bone Mineral Density as a Surrogate Endpoint for Fracture Outcomes: The FNIH-ASBMR SABRE ProjectRichard Eastell, Eric Vittinghoff, Li-Yung Lui, et al.
BMJ (Clinical Research Ed.)|July 1, 2021
Burden, treatment use, and outcome of secondary mitral regurgitation across the spectrum of heart failure: observational cohort studyPhilipp E Bartko, Gregor Heitzinger, Noemi Pavo, et al.
Pageof 33